Hemispherx BioPharma (HEB) Stock Chart & Stock Price History $6.70 -1.68 (-20.05%) As of 06/13/2025 Add Compare Share Share Chart Stock AnalysisChartSEC FilingsBuy This Stock Hemispherx BioPharma Stock Price Performance The Hemispherx BioPharma (HEB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 3,283.84%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Hemispherx BioPharma traded at $6.70 with a market cap of $16.36 million and volume of 7,639 shares. Receive HEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemispherx BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance0.00%Year-To-Date Performance+3,283.84% HEB Stock Chart for Tuesday, August, 5, 2025 HEB Chart by TradingView Hemispherx BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million08/01/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/31/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/30/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/29/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/28/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/25/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/24/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/23/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/22/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million Get the Latest News and Ratings for HEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemispherx BioPharma and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/18/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/17/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/16/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/15/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/14/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/11/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/10/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/09/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/08/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/07/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million07/04/2025$6.70$6.70$9.00$5.807,639 shs$16.36 million Related Companies HYPD Stock Chart IBIO Stock Chart BRTX Stock Chart PHGE Stock Chart PHXM Stock Chart LIAN Stock Chart ADIL Stock Chart NMTR Stock Chart RSPID Stock Chart KLDO Stock Chart Receive HEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemispherx BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:HEB) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemispherx BioPharma, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemispherx BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HEB Stock Alerts